NCT04246294

Brief Summary

This project will assess patients with diagnosed obstructive sleep apnea, to investigate the impact of poor sleep on central pain mechanisms. Furthermore, the project will explore if restoring good sleep hygiene can improve the central pain mechanisms that may be associated with the risk of chronic pain.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
6

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Feb 2020

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 23, 2020

Completed
6 days until next milestone

First Posted

Study publicly available on registry

January 29, 2020

Completed
3 days until next milestone

Study Start

First participant enrolled

February 1, 2020

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2022

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2022

Completed
Last Updated

February 6, 2023

Status Verified

February 1, 2023

Enrollment Period

2.2 years

First QC Date

January 23, 2020

Last Update Submit

February 3, 2023

Conditions

Keywords

Sleep ApneaContinuous Positive Airway PressureTemporal Summation of PainConditioned Pain ModulationPain CatastrophizingPain DetectLongitudinal, follow-up

Outcome Measures

Primary Outcomes (1)

  • Change in daytime sleepiness due to sleep apnea

    Daytime sleepiness as assessed by Epworth Sleepiness Scale, will be evaluated as a change from before treatment initiation (min value: 0 (no daily sleepiness); max value (24) - higher score associated with increased sleepiness)

    Baseline - 1 month- 12 months after initiation of sleep apnea treatment

Secondary Outcomes (5)

  • Change in pain inihibition and facilitation

    Baseline - 1 month- 12 months after initiation of sleep apnea treatment

  • PainDetect

    Baseline - 1 month- 12 months after initiation of sleep apnea treatment

  • Pain Catastrophizing Scale

    Baseline - 1 month- 12 months after initiation of sleep apnea treatment

  • Pain intensity

    Baseline - 1 month- 12 months after initiation of sleep apnea treatment

  • Continuous Positive Airway Pressure compliance (percentage who continues using the device for the optimum amount of time each night) and adherence (the percentage of patients who abandon treatment completely)

    Baseline - 1 month- 12 months after initiation of sleep apnea treatment

Study Arms (1)

Sleep apnea patients

This group of patients will have been monitored over night with cardiorespiratory monitoring (CRM). CRM enables the physician to establish an Apnea-Hypopnea Index (AHI) which will be used for diagnosis. An AHI \> 15 is considered moderate-to-severe sleep apnea, and this is the focus group of patients in the current project. These patients will be followed for 12 months during continuous positive airway pressure (CPAP) treatment. Adherence to the CPAP treatment will be closely monitored.

Device: Continuous Positive Airway Pressure (CPAP)

Interventions

CPAP is golden standard treatment for moderate-to-severe sleep apnea with high compliance, effectiveness, and cost-effectiveness. There will be no interference with standard care.

Sleep apnea patients

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Men and women presenting with an apnea-hypopnea (AHI) index \> 15 (moderate-to-severe sleep apnea) measured by cardiorespiratory monitoring (CRM) \[10\] and scheduled for treatment at Søvncenter Nord

You may qualify if:

  • Men and women presenting with an apnea-hypopnea (AHI) index \> 15 (moderate-to-severe sleep apnea) measured by cardiorespiratory monitoring (CRM) and scheduled for treatment at Søvncenter Nord
  • Age 18-80

You may not qualify if:

  • Pregnancy
  • Intake of drugs labelled with the red warning triangle and misuse of cannabis and opioids
  • No previous or current neurologic or mental illnesses
  • Lack of ability to cooperate
  • Non-fluent in Danish (reading, speaking, and comprehension)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Otorhinolaryngology, Sleep Center North, Aalborg University Hospital

Aalborg, North Denmark, 9000, Denmark

Location

MeSH Terms

Conditions

Sleep Apnea Syndromes

Interventions

Continuous Positive Airway Pressure

Condition Hierarchy (Ancestors)

ApneaRespiration DisordersRespiratory Tract DiseasesSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System Diseases

Intervention Hierarchy (Ancestors)

Positive-Pressure RespirationRespiration, ArtificialAirway ManagementTherapeuticsRespiratory Therapy

Study Officials

  • Dennis B Larsen, PhD

    Aalborg University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

January 23, 2020

First Posted

January 29, 2020

Study Start

February 1, 2020

Primary Completion

May 1, 2022

Study Completion

October 1, 2022

Last Updated

February 6, 2023

Record last verified: 2023-02

Data Sharing

IPD Sharing
Will not share

Locations